Fred Alger Management, LLC Axogen, Inc. Transaction History

Fred Alger Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$7.35 - $10.81 $4,343 - $6,388	-591 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$11.18 - $18.6 $1.03 Million - $1.72 Million	-92,299 Reduced 99.36%	591 $11,000
Q3 2019 Nov 14, 2019	SELL	$12.09 - $20.46 $12 - $20	-1 Reduced -0.0%	92,890 $1.16 Million
Q2 2019 Aug 14, 2019	SELL	$18.5 - $25.47 $126,706 - $174,444	-6,849 Reduced 6.87%	92,891 $1.84 Million
Q1 2019 May 14, 2019	SELL	$14.62 - $22.13 $25,628 - $38,793	-1,753 Reduced 1.73%	99,740 $2.1 Million
Q4 2018 Feb 14, 2019	SELL	$17.09 - $38.25 $1.73 Million - $3.87 Million	-101,300 Reduced 49.95%	101,493 $2.07 Million
Q3 2018 Nov 14, 2018	SELL	$34.05 - $55.9 $6.96 Million - $11.4 Million	-204,320 Reduced 50.19%	202,793 $7.47 Million
Q2 2018 Jul 19, 2018	BUY	$36.15 - $52.5 $12 Million - $17.4 Million	332,025 Added 442.18%	407,113 $20.5 Million
Q1 2018 May 10, 2018	BUY	$24.4 - $40.25 $1.83 Million - $3.02 Million	75,088 New	75,088 $2.74 Million

165

36.1M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $778M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fred Alger Management, LLC with notifications on news.